Abstract
Multiple sclerosis (MS) is a chronic demyelinating disease of central nervous system regarded as one of the most common causes of neurological disability in young adults. The exact etiology of MS is not yet known, although epidemiological data indicate that both genetic susceptibility and environmental exposure are involved. A poor vitamin D status has been proposed as the most attractive environmental factor. Several evidence have highlighted the importance of mutations in vitamin D-regulating genes for vitamin D status. The purpose of our study was to assess the genetic variants of VDBP and CYP27B1 in MS patients and in a control group. A total of 192 subjects, including 100 MS patients and 92 healthy controls, were genotyped by polymerase chain reaction followed by restriction fragment length polymorphism analyses. Serum 25-hydroxyvitamin D levels were measured in MS patients and controls by high-performance liquid chromatography. We did not observe any statically significant difference in the distribution of genotypic VDBP variants between the study groups. 25(OH)D plasma levels were significantly higher in the control group versus MS patients; MS patients who carried Gc2 showed lower 25(OH)D plasma levels and those who carried Gc1f showed higher levels. We observed only wild-type allele for CYP27B1 mutations analyzed both in MS patients and in the control group. In conclusion, our findings do not support a role of an independent effect of the investigated vitamin D-related gene variants, VDBP and CYP27B1, in the risk of MS.
Similar content being viewed by others
Abbreviations
- EDSS:
-
Expanded Disability Status Scale
- MSSS:
-
Multiple Sclerosis Severity Score
- ARR:
-
Annualized Relapse Rates
References
Agnello L, Scazzone C, Ragonese P, Salemi G, Lo Sasso B, Schillaci R, Musso G, Bellia C, Ciaccio M (2016) Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients. Neurol Sci 37(2):261–267
Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19(13):2739–2745
Australian and New Zealand Multiple Sclerosis Genetics Consortium (2009) Genome-wide association study identifies new multiple sclerosis loci on chromosomes 12 and 20. Nat Genet 41(7):824–828
Baier LJ, Dobberfuhl AM, Pratley RE, Hanson RL, Bogardus C (1998) Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab 83(8):2993–2996
Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A (2013) No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann Neurol 73(3):430–432
Barizzone N, Pauwels I, Luciano B, Franckaert D, Guerini FR, Cosemans L, Hilven K, Salviati A, Dooley J, Danso-Abeam D, di Sapio A, Cavalla P, Decallonne B, Mathieu C, Liston A, Leone M, Dubois B, D’Alfonso S, Goris A (2013) No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis. Ann Neurol 73(3):433–437
Beretich BD, Beretich TM (2009) Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler 15(8):891–898
Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P (1981) Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest 67(3):589–596
Chun Rene F, Lauridsen Anna L, Suon Lizabeth, Zella Lee A, Wesley Pike J, Modlin Robert L, Martineau Adrian R, Wilkinson Robert J, Adams John, Hewison Martin (2010) Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25 dihydroxyvitamin D. J Clin Endocrinol Metab 95(7):3368–3376
Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M (2014) Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144:132–137
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517
Disanto G, Ramagopalan SV, Para AE, Handunnetthi L (2011) The emerging role of vitamin D binding protein in multiple sclerosis. J Neurol 258(3):353–358
Engelman CD, Meyers KJ, Ziegler JT, Taylor KD, Palmer ND, Haffner SM, Fingerlin TE, Wagenknecht LE, Rotter JI, Bowden DW, Langefeld CD, Norris JM (2010) Genome-wide association study of vitamin D concentrations in Hispanic Americans: the IRAS family study. J Steroid Biochem Mol Biol 122(4):186–192
Goldberg P (1974) Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. Int J Environ Stud 6(2–3):121–129
Hewison M (2012) Vitamin D and immune function: an overview. Proc Nutr Soc 71(1):50–61
Jolliffe DA, Walton RT, Griffiths CJ, Martineau AR (2015) Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: review of genetic association studies. J Steroid Biochem Mol Biol. doi:10.1016/j.jsbmb.2015.12.007
Jorde R, Schirmer H, Wilsgaard T, Bøgeberg Mathiesen E, Njølstad I, Løchen ML, Joakimsen RM, Grimnes G (2015) The DBP phenotype Gc-1f/Gc-1f is associated with reduced risk of cancer The Tromsø study. PLoS ONE 10(5):e0126359
Niino M (2010) Vitamin D and its immunoregulatory role in multiple sclerosis. Drugs Today 46(4):279–290
Niino M, Kikuchi S, Fukazawa T, Yabe I, Tashiro K (2002) No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS. J Neuroimmunol 127(1–2):177–179
Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC (2011) Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 305(1–2):116–120
Pierrot-Deseilligny C, Souberbielle JC (2013) Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord 6(2):81–116
Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9(7):727–739
Ramagopalan SV, Dyment DA, Cader MZ, Morrison KM, Disanto G, Morahan JM, Berlanga-Taylor AJ, Handel A, De Luca GC, Sadovnick AD, Lepage P, Montpetit A, Ebers GC (2011) Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann Neurol 70(6):881–886
Reinthaler E, Machetanz G, Hotzy C, Reindl M, Fazekas F, Kristoferitsch W, Berger T, Schmied C, Zimprich A (2014) No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients. Mult Scler 20(3):391–392
Shahijanian F, Parnell GP, McKay FC, Gatt PN, Shojoei M, O’Connor KS, Schibeci SD, Brilot F, Liddle C, Batten M, ANZgene Multiple Sclerosis Genetics Consortium, Stewart GJ, Booth DR (2014) The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells. Hum Mol Genet 23(6):1425–1434
Simon KC, Munger KL, Yang Xing, Ascherio A (2010) Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler 16(2):133–138
Smolders J, Damoiseaux J, Menheere P, Hupperts R (2008) Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 194(1–2):7–17
Steckley JL, Dyment DA, Sadovnick AD, Risch N, Hayes C, Ebers GC (2000) Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients Canadian Collaborative Study Group. Neurology 54(3):729–732
Wang JT, Lin CJ, Burridge SM, Fu GK, Labuda M, Portale AA, Miller WL (1998) Genetics of vitamin D 1 alpha-hydroxylase deficiency in 17 families. Am J Hum Genet 63(6):1694–1702
Wang X, Zhang MY, Miller WL, Portale AA (2002) Novel gene mutations in patients with 1 alpha-hydroxylase deficiency that confer partial enzyme activity in vitro. J Clin Endocrinol Metab 87(6):2424–2430
Wjst M, Altmüller J, Braig C, Bahnweg M, André E (2007) A genome-wide linkage scan for 25-OH-D(3) and 1,25-(OH)2-D3 serum levels in asthma families. J Steroid Biochem Mol Biol 103(3–5):799–802
Author information
Authors and Affiliations
Corresponding author
Additional information
L. Agnello and C. Scazzone have contributed equally to the study.
Rights and permissions
About this article
Cite this article
Agnello, L., Scazzone, C., Lo Sasso, B. et al. VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients. Biochem Genet 55, 183–192 (2017). https://doi.org/10.1007/s10528-016-9783-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-016-9783-4